BioSpace News Archive

Napo Pharmaceuticals, a Jaguar Health, Inc. family company, announced that a Multinational Association of Supportive Care in Cancer webinar titled “GI Toxicities from Cancer Therapies - Prevention and Management,” taking place Monday, January 29, 2024 from 11:30 AM to 12:30 PM Eastern Standard Time, was made possible by an unrestricted educational grant from Napo.

BrainStorm Cell Therapeutics Inc. today announced the completion of a productive meeting with the U.S. Food and Drug Administration (FDA) to discuss NurOwn®, its investigational treatment for amyotrophic lateral sclerosis (ALS).

The global anesthesia drugs market size was valued at USD 460 million in 2022 to anticipated around USD 1,530 million by 2032, expanding at a CAGR of 13.3% between 2023 and 2032.

Cogent Biosciences, Inc. today presented updated preclinical data from its potent, selective and brain penetrant ErbB2 inhibitor program at the 2023 San Antonio Breast Cancer Symposium (SABCS), taking place December 5-9, 2023 at the Henry B. González Convention Center in San Antonio, Texas.

SciSparc Ltd. announced updates regarding the negotiation following the signing of a non-binding letter of intent with a leading vehicle importer company in Israel, on November 22, 2023.

10x Genomics, Inc., a leader in single cell and spatial biology, announced a collaboration with the NIH Intramural Center for Alzheimer’s and Related Dementias to build a more comprehensive single cell atlas of the human brain to further neuroscience research.

Kintara Therapeutics, Inc. announced that its Board of Directors has initiated a process to explore and review a range of strategic alternatives focused on maximizing stockholder value.

Levita Magnetics, whose mission is to help more patients get access to better surgery, announced today the international launch of its MARS surgical system at Hospital Luis Tisne in Santiago, Chile.

SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, announced an expanded suite of solutions under SOPHiA DDM™ for Liquid Biopsy.

Pillar Biosciences is pleased to announce that Randy Pritchard , Chief Executive Officer, and Vincent Ricci , Chief Financial Officer, will be presenting at the NYBIO | NYSE Life Science Company Showcase on December 14th.